Seroprevalence of measles mumps rubella and varicella antibodies in the United States population 2009-2010.

Monday, 15th of August 2016 Print

Open Forum Infect Dis. 2015 Feb 20;2(1):ofv006. doi: 10.1093/ofid/ofv006. eCollection 2015.

Seroprevalence of measles mumps rubella and varicella antibodies in the United States population 2009-2010.

Lebo EJ1 Kruszon-Moran DM2 Marin M1 Bellini WJ1 Schmid S1 Bialek SR1 Wallace GS1 McLean HQ3.

Author information

Abstract

Background.  In the United States measles mumps rubella and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary. Methods.  We evaluated seroprevalence of antibodies to measles mumps rubella and varicella using the National Health and Nutrition Examination Survey during 2009-2010. Results.  Measles mumps rubella and varicella seroprevalence was 92.0% (95% confidence interval [CI] 90.9%-93.0%) 87.6% (CI 85.8%-89.2%) 95.3% (CI 94.3%-96.2%) and 97.8% (CI 97.1%-98.3%) respectively. United States (US)-born persons had lower mumps seroprevalence and higher varicella seroprevalence than non-US born persons. Conclusions.  Seroprevalence was high (88%-98%) for all 4 viruses in the US population during 2009-2010.

 

Special Postings

;

Highly Accessed

Website Views

47432819